StockNews.com Begins Coverage on Marinus Pharmaceuticals (NASDAQ:MRNS)
StockNews.com initiated coverage on shares of Marinus Pharmaceuticals (NASDAQ:MRNS – Get Free Report) in a report released on Tuesday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Marinus Pharmaceuticals Stock Performance NASDAQ:MRNS opened at $0.55 on Tuesday. The stock has a market capitalization of $30.32 million, a P/E ratio of -0.22 and […]
